Team Ossiform


New EU and US Regulations Greenlight the Refinement of Global Non-Animal Testing Strategies – AMS Speaker Spotlight

The Modernization Act 2.0, set in motion by the FDA and signed by President Joe Biden, together with the Directive 2010/63/EU regulations, increases awareness about the use of animal testing…


AMS Speaker Spotlight: 3D Printed Bioceramics for Better Patient Outcomes

Ossiform’s CCO, Casper Slots, will be participating in Additive Manufacturing Strategies 2022, Panel 3: Markets for Printable Biomaterials. Ossiform has developed a proprietary technology, involving a novel formulation of biomaterials…